Tissue-Type Plasminogen Activator Is a Multiligand Cross-β Structure Receptor
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Current Biology
- Vol. 12 (21), 1833-1839
- https://doi.org/10.1016/s0960-9822(02)01224-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesisJournal of Molecular Biology, 2001
- Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid‐β Neurotoxicity and DepositionJournal of Neurochemistry, 2000
- Amyloid Fibril Formation from Full-Length and Fragments of AmylinJournal of Structural Biology, 2000
- Modulation of fibrin assembly and polymerization by the ??-amyloid of Alzheimer??s diseaseBlood Coagulation & Fibrinolysis, 1996
- Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activatorNature, 1995
- In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical informationBiochemistry, 1992
- Methods for Staining Amyloid in Tissues: A ReviewStain Technology, 1988
- Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin.The Journal of Experimental Medicine, 1983
- ORIENTATION OF FIBRIN IN STRONG MAGNETIC FIELDSAnnals of the New York Academy of Sciences, 1983